Transanal eco-Doppler evaluation after hemorrhoidal artery embolization

Table 1 Patient demographics and pre-treatment symptom severity

Patient	Age	Sex	Comorbidities	Anticoagulant therapy	Goligher score	Pre-treatment HBS
1	56	F	No comorbidities	No therapy	3	5
2	43	F	No comorbidities	No therapy	3	6
3	75	M	Atrial fibrillation	Warfarin	3	4
4	54	F	Hypothyroidism	No therapy	2	5
5	62	M	No comorbidities	No therapy	3	6
6	53	M	No comorbidities	No therapy	3	3
7	46	F	No comorbidities	No therapy	2	4
8	46	M	No comorbidities	No therapy	3	3
9	63	F	No comorbidities	No therapy	3	4
10	55	M	No comorbidities	No therapy	2	5
11	28	M	No comorbidities	No therapy	3	3

HBS: Hemorrhoidal bleeding score.

Table 2 Sectorial pre- and post-treatment systolic peaks

Patient	1 o’clock		3 o’clock		5 o’clock		6 o’clock		7 o’clock		9 o’clock		11 o’clock		12 o’clock
	Pre	Post	Pre	Post	Pre	Post	Pre	Post	Pre	Post	Pre	Post	Pre	Post	Pre	Post
1	9.61	13.10	5.12	5.44	9.50	6.19	20.50	14.90	15.00	9.93	7.47	10.80	20.10	17.40	6.62	13.00
2	20.40	5.12	24.91	16.10	15.90	8.11	24.90	13.10	10.90	6.62	15.40	14.90	6.50	8.11	10.40	20.50
3	17.00	19.90	10.70	17.00	13.70	19.40	8.86	8.97	15.80	12.40	8.97	22.60	12.00	14.40	20.00	14.90
4	13.10	20.40	18.50	20.40	16.19	7.36	6.19	6.83	12.00	9.61	19.40	15.80	13.00	8.00	21.00	24.90
5	25.40	25.20	16.90	10.60	6.62	7.58	8.65	8.00	13.60	10.60	26.40	20.20	19.40	14.10	15.00	7.47
6	20.50	14.50	15.50	8.43	8.11	13.00	7.79	9.39	13.20	8.22	12.80	14.30	7.36	13.70	10.10	5.87
7	17.70	ND	16.40	ND	8.22	ND	8.86	ND	19.40	ND	13.80	ND	8.11	ND	8.65	ND
8	17.40	20.40	15.60	13.60	8.11	8.65	12.70	8.22	15.50	7.79	25.00	15.70	20.50	15.30	15.50	8.00
9	24.00	20.40	25.00	6.51	8.00	6.40	15.70	8.22	11.20	12.20	18.60	14.30	11.00	19.00	16.20	8.86
10	5.90	14.10	13.00	13.00	20.00	11.60	7.79	7.79	8.22	8.97	10.00	4.38	12.70	8.00	5.70	5.87
11	25.00	ND	13.10	ND	29.00	ND	25.00	ND	26.00	ND	26.00	ND	9.50	ND	15.20	ND
Mean	17.82	17.01	15.88	12.34	13.03	9.81	13.36	9.49	14.62	9.59	16.71	14.77	12.74	13.11	13.12	12.15

Systolic peak data are in cm/s. ND: Not defined.

Table 3 Superior rectal artery classification, Emborrhoid treatment, and outcomes

Patient	SRA classification	Type of embolization	Pre-treatment MSP	Post-treatment MSP	Pre-treatment HBS	Post-treatment HBS
1	Type 1	Distal (particles and coils)	11.74	11.34	5	0
2	Type 1	Distal (particles and coils)	16.16	11.57	6	0
3	Type 2	Proximal (particles and coils; coils in SRA/MRA anastomosis)	13.38	16.20	4	4
4	Type 1	Proximal (particles and coils)	14.92	14.16	5	0
5	Type 1	Distal (particles and coils)	16.50	12.97	6	4
6	Type 2	Distal (particles and coils; particles and coils in SRA/MRA anastomosis)	11.92	10.93	3	0
7	Type 1	Distal (particles and coils)	12.64	ND	4	ND
8	Type 1	Distal (particles and coils)	16.29	12.21	3	0
9	Type 1	Distal (particles distally; one coil proximal)	16.21	11.99	4	4
10	Type 1	Distal (coils)	10.41	9.21	5	3
11	Type 2	Proximal (particles and coils; particles and coils in SRA/MRA anastomosis)	21.10	ND	3	ND

HBS: Hemorrhoidal bleeding score; MRA: Middle rectal artery; MSP: Mean systolic peak; ND: Not defined; SRA: Superior rectal artery.

Table 4 Overall pre- and post-treatment mean systolic peak

Position	Pre-treatment MSP	Post-treatment MSP	P value
1 o’clock	17.82	17.01	0.993
3 o’clock	15.88	12.34	0.158
5 o’clock	13.03	9.81	0.314
6 o’clock	13.36	9.49	0.077
7 o’clock	14.62	9.59	0.008
9 o’clock	16.71	14.77	0.604
11 o’clock	12.74	13.11	0.708
12 o’clock	13.12	12.15	0.592
Overall	14.66	12.29	0.008

Systolic peak data are in cm/s. MSP: Mean systolic peak.